ProMIS Neurosciences Inc. - 8-K Filing
ProMIS Neurosciences reports Q3 2026 net loss of $8.2 million and reaffirms Q1 2027 topline data timing for PRECISE-AD trial. (Items: 2.02 Results of Operations and Financial ConditionOn November 12, 2026, ProMIS Neurosciences Inc, 9.01 Financial Statements and Exhibits)